Vaxxinity Balance Sheet Health
Financial Health criteria checks 3/6
Vaxxinity has a total shareholder equity of $13.4M and total debt of $15.2M, which brings its debt-to-equity ratio to 113.1%. Its total assets and total liabilities are $44.3M and $30.9M respectively.
Key information
113.1%
Debt to equity ratio
US$15.17m
Debt
Interest coverage ratio | n/a |
Cash | US$30.64m |
Equity | US$13.41m |
Total liabilities | US$30.90m |
Total assets | US$44.31m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: VAXX's short term assets ($33.2M) exceed its short term liabilities ($17.6M).
Long Term Liabilities: VAXX's short term assets ($33.2M) exceed its long term liabilities ($13.3M).
Debt to Equity History and Analysis
Debt Level: VAXX has more cash than its total debt.
Reducing Debt: Insufficient data to determine if VAXX's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if VAXX has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if VAXX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.